MedPlus Health Services Statistics

Total Valuation

NSE:MEDPLUS has a market cap or net worth of INR 109.58 billion. The enterprise value is 117.10 billion.

Market Cap	109.58B
Enterprise Value	117.10B

Important Dates

The last earnings date was Tuesday, May 27, 2025.

Earnings Date	May 27, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:MEDPLUS has 119.74 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	119.74M
Shares Outstanding	119.74M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.61%
Owned by Insiders (%)	13.48%
Owned by Institutions (%)	35.41%
Float	69.17M

Valuation Ratios

The trailing PE ratio is 73.10 and the forward PE ratio is 52.77. NSE:MEDPLUS's PEG ratio is 1.60.

PE Ratio	73.10
Forward PE	52.77
PS Ratio	1.79
PB Ratio	6.30
P/TBV Ratio	6.49
P/FCF Ratio	22.78
P/OCF Ratio	20.28
PEG Ratio	1.60

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.04, with an EV/FCF ratio of 24.35.

EV / Earnings	77.90
EV / Sales	1.91
EV / EBITDA	24.04
EV / EBIT	49.36
EV / FCF	24.35

Financial Position

The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.64.

Current Ratio	3.20
Quick Ratio	0.66
Debt / Equity	0.64
Debt / EBITDA	2.30
Debt / FCF	2.33
Interest Coverage	2.31

Financial Efficiency

Return on equity (ROE) is 9.06% and return on invested capital (ROIC) is 5.45%.

Return on Equity (ROE)	9.06%
Return on Assets (ROA)	4.66%
Return on Invested Capital (ROIC)	5.45%
Return on Capital Employed (ROCE)	8.52%
Revenue Per Employee	2.62M
Profits Per Employee	64,199
Employee Count	23,415
Asset Turnover	1.93
Inventory Turnover	3.46

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.27% in the last 52 weeks. The beta is 0.74, so NSE:MEDPLUS's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	+31.27%
50-Day Moving Average	831.45
200-Day Moving Average	757.65
Relative Strength Index (RSI)	55.64
Average Volume (20 Days)	284,069

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:MEDPLUS had revenue of INR 61.36 billion and earned 1.50 billion in profits. Earnings per share was 12.52.

Revenue	61.36B
Gross Profit	14.95B
Operating Income	2.37B
Pretax Income	1.83B
Net Income	1.50B
EBITDA	3.14B
EBIT	2.37B
Earnings Per Share (EPS)	12.52

Full Income Statement

Balance Sheet

The company has 3.67 billion in cash and 11.20 billion in debt, giving a net cash position of -7.53 billion or -62.85 per share.

Cash & Cash Equivalents	3.67B
Total Debt	11.20B
Net Cash	-7.53B
Net Cash Per Share	-62.85
Equity (Book Value)	17.40B
Book Value Per Share	146.47
Working Capital	12.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.40 billion and capital expenditures -594.50 million, giving a free cash flow of 4.81 billion.

Operating Cash Flow	5.40B
Capital Expenditures	-594.50M
Free Cash Flow	4.81B
FCF Per Share	40.17

Full Cash Flow Statement

Margins

Gross margin is 24.37%, with operating and profit margins of 3.87% and 2.45%.

Gross Margin	24.37%
Operating Margin	3.87%
Pretax Margin	2.99%
Profit Margin	2.45%
EBITDA Margin	5.12%
EBIT Margin	3.87%
FCF Margin	7.84%

Dividends & Yields

NSE:MEDPLUS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	n/a
Earnings Yield	1.37%
FCF Yield	4.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a